Predicate |
Object |
contentType |
Journal Article |
endingPage |
E727 |
issn |
1550-7416 |
issueIdentifier |
3 |
pageRange |
E723-E727 |
publicationName |
The AAPS Journal |
startingPage |
E723 |
bibliographicCitation |
Melethil S. Patent issues in drug development: perspectives of a pharmaceutical scientist-attorney. AAPS J. 2005 Oct 27;7(3):E723–8. PMID: 16353948; PMCID: PMC2751274. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7dbdd3715b1e99042db79d13471ab2f3 |
date |
2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1208/aapsj070372 https://pubmed.ncbi.nlm.nih.gov/16353948 https://pubmed.ncbi.nlm.nih.gov/PMC2751274 |
isPartOf |
https://portal.issn.org/resource/ISSN/1550-7416 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32024 |
language |
English |
source |
https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Patent issues in drug development: Perspectives of a pharmaceutical scientist-attorney |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3386 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36431 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10325 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62857 |